论文部分内容阅读
目的 探讨病人血清肿瘤标志物DR - 70 TM 的检测对恶性肿瘤的诊断价值。方法 采用DR - 70诊断试剂盒 ,应用ELISA技术对各种恶性肿瘤患者测定其血清DR - 70 TM含量 ,并设正常人对照组进行对比。结果 恶性肿瘤组 112例 ,DR - 70 TM 阳性率为 81 3% ,健康人对照组 5 4例 ,阳性率为 9 3% ,两组比较有显著性差异(P <0 0 1)。结论 检测DR - 70 TM对多种恶性肿瘤的早期诊断有一定参考价值 ,可进一步深入研究。
Objective To investigate the diagnostic value of the patient’s serum tumor marker DR-70TM in the diagnosis of malignant tumors. Methods The DR-70 diagnostic kit was used to determine the serum DR-70TM levels in patients with various malignant tumors by ELISA. The normal control group was used for comparison. Results Of the 112 patients with malignant tumors, the positive rate of DR-70 TM was 81. 3%, the healthy control group was 54 and the positive rate was 93%. There was a significant difference between the two groups (P <0 01). Conclusion The detection of DR-70TM has certain reference value for the early diagnosis of various malignant tumors and can be further studied.